Cargando…
Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial
BACKGROUND: Uncontrolled active rheumatoid arthritis can lead to increasing disability and reduced quality of life over time. ‘Treating to target’ has been shown to be effective in active established disease and also in early disease. However, there is a lack of nationally agreed treatment protocols...
Autores principales: | Martin, Naomi H., Ibrahim, Fowzia, Tom, Brian, Galloway, James, Wailoo, Allan, Tosh, Jonathan, Lempp, Heidi, Prothero, Louise, Georgopoulou, Sofia, Sturt, Jackie, Scott, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723045/ https://www.ncbi.nlm.nih.gov/pubmed/29221496 http://dx.doi.org/10.1186/s13063-017-2330-8 |
Ejemplares similares
-
The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: The titrate trial
por: Scott, David, et al.
Publicado: (2020) -
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Lee, Sook Yan, et al.
Publicado: (2021) -
Intensive management for moderate rheumatoid arthritis: a qualitative study of patients’ and practitioners’ views
por: Prothero, Louise, et al.
Publicado: (2019) -
Patient involvement in the development of a handbook for moderate rheumatoid arthritis
por: Prothero, Louise, et al.
Publicado: (2016) -
Development of the Rheumatoid Arthritis Distress Scale (RADS): a new tool to identify disease-specific distress in patients with Rheumatoid Arthritis
por: Silke, Linda, et al.
Publicado: (2021)